Compare GIL & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIL | ELAN |
|---|---|---|
| Founded | 1946 | 1954 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 10.3B |
| IPO Year | 1998 | 2018 |
| Metric | GIL | ELAN |
|---|---|---|
| Price | $64.98 | $24.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $74.50 | $24.44 |
| AVG Volume (30 Days) | 1.1M | ★ 4.8M |
| Earning Date | 02-18-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.37% | N/A |
| EPS Growth | ★ 24.08 | N/A |
| EPS | ★ 3.13 | 0.07 |
| Revenue | $3,362,263,000.00 | ★ $4,591,000,000.00 |
| Revenue This Year | $7.50 | $7.25 |
| Revenue Next Year | $100.40 | $5.69 |
| P/E Ratio | ★ $20.61 | $341.76 |
| Revenue Growth | ★ 4.04 | 3.08 |
| 52 Week Low | $37.16 | $8.02 |
| 52 Week High | $67.96 | $25.29 |
| Indicator | GIL | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 55.05 |
| Support Level | $64.30 | $24.27 |
| Resistance Level | $67.40 | $25.03 |
| Average True Range (ATR) | 1.69 | 0.66 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 51.53 | 41.29 |
Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. Its primary market is the sale of blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels. Brands include Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generates nearly 90% of its sales in the US. Gildan is acquiring its US rival Hanesbrands to bolster its consumer and printwear operations.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.